Nuvation Bio Inc. (NUVB)
NYSE·Healthcare·Biotechnology
$6.14
-2.15%
Mkt Cap $2.36B
Analyst Ratings
Buy
11
Hold
0
Sell
0
Price Target (18 analysts)
$16.00
Range $13.00 – $19.00
Implied Upside
+160.8%
Consensus $16.00 vs current $6.14
NYSE·Healthcare·Biotechnology
$6.14
-2.15%
Mkt Cap $2.36B
Buy
11
Hold
0
Sell
0
Price Target (18 analysts)
$16.00
Range $13.00 – $19.00
+160.8%
Consensus $16.00 vs current $6.14